ZEPP HEALTH CORP-ADR (ZEPP)

US98945L1052 - ADR

0.8706  +0.02 (+2.06%)

Fundamental Rating

2

Taking everything into account, ZEPP scores 2 out of 10 in our fundamental rating. ZEPP was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. ZEPP may be in some trouble as it scores bad on both profitability and health. ZEPP is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZEPP has reported negative net income.
ZEPP had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZEPP reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ZEPP reported negative operating cash flow in multiple years.

1.2 Ratios

The profitability ratios for ZEPP are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)0.22%
ROA(5y)3.04%
ROE(3y)0.77%
ROE(5y)6.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 19.39%, ZEPP is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
ZEPP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ZEPP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.44%
GM growth 5Y-4.3%

More info and screens

1

2. Health

2.1 Basic Checks

ZEPP does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZEPP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.87%

2.3 Liquidity

ZEPP has a Current Ratio of 1.77. This is a normal value and indicates that ZEPP is financially healthy and should not expect problems in meeting its short term obligations.
ZEPP's Current ratio of 1.77 is on the low side compared to the rest of the industry. ZEPP is outperformed by 69.84% of its industry peers.
ZEPP has a Quick Ratio of 1.16. This is a normal value and indicates that ZEPP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ZEPP (1.16) is worse than 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.16

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ZEPP have decreased strongly by -325.00% in the last year.
Looking at the last year, ZEPP shows a very negative growth in Revenue. The Revenue has decreased by -33.71% in the last year.
The Revenue has been growing by 15.12% on average over the past years. This is quite good.
EPS 1Y (TTM)-325%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)-33.71%
Revenue growth 3Y-10.67%
Revenue growth 5Y15.12%
Revenue growth Q2QN/A

3.2 Future

ZEPP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 76.14% yearly.
The Revenue is expected to decrease by -13.63% on average over the next years. This is quite bad
EPS Next Y-52.5%
EPS Next 2Y89.58%
EPS Next 3Y76.14%
EPS Next 5YN/A
Revenue Next Year-40.03%
Revenue Next 2Y-26.27%
Revenue Next 3Y-13.63%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ZEPP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 11.41, the valuation of ZEPP can be described as very reasonable.
87.30% of the companies in the same industry are more expensive than ZEPP, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ZEPP to the average of the S&P500 Index (21.32), we can say ZEPP is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.41

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ZEPP's earnings are expected to grow with 76.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.58%
EPS Next 3Y76.14%

More info and screens

0

5. Dividend

5.1 Amount

ZEPP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEPP HEALTH CORP-ADR

NYSE:ZEPP (4/29/2024, 7:04:00 PM)

0.8706

+0.02 (+2.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap53.14M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.41
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 1.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-325%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-52.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-33.71%
Revenue growth 3Y-10.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y